Singapore markets open in 8 hours 30 minutes

Straits Times Index
3,296.89
+4.20(+0.13%)
S&P 500
5,037.42
+19.03(+0.38%)
Dow
38,046.98
+143.69(+0.38%)
Nasdaq
15,732.34
+126.85(+0.81%)
Bitcoin USD
59,174.94
+1,950.06(+3.41%)
CMC Crypto 200
1,289.06
+18.32(+1.44%)

DGX May 2024 135.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.6000

-1.2000

(-31.58%)

As of 11:38AM EDT. Market open.

Zacks
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
PR Newswire
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
Simply Wall St.
Quest Diagnostics Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...